IPO Boutique

Newsummit Biopharma Holdings IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Newsummit Biopharma Holdings, and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Newsummit Biopharma HoldingsNSB -
NYSE
TBD $0.00 $0.00TBD
Oppenheimer & Co., Cowen & Co.
Co-Manager(s):
Filing(s):

Filed 2012-02-24



About Newsummit Biopharma Holdings (adapted from Newsummit Biopharma Holdings prospectus):
They are a leading China-based new drug development process solutions provider.

This description is adapted from Newsummit Bio prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as Newsummit Bio "NSB" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved